KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Research & Development: 2009-2024

Historic Research & Development for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $431.2 million.

  • Exact Sciences' Research & Development rose 15.57% to $117.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.2 million, marking a year-over-year decrease of 4.34%. This contributed to the annual value of $431.2 million for FY2024, which is 1.00% up from last year.
  • As of FY2024, Exact Sciences' Research & Development stood at $431.2 million, which was up 1.00% from $426.9 million recorded in FY2023.
  • Exact Sciences' 5-year Research & Development high stood at $554.1 million for FY2020, and its period low was $385.6 million during FY2021.
  • Its 3-year average for Research & Development is $417.4 million, with a median of $426.9 million in 2023.
  • As far as peak fluctuations go, Exact Sciences' Research & Development skyrocketed by 296.64% in 2020, and later crashed by 30.40% in 2021.
  • Yearly analysis of 5 years shows Exact Sciences' Research & Development stood at $554.1 million in 2020, then slumped by 30.40% to $385.6 million in 2021, then climbed by 2.22% to $394.2 million in 2022, then rose by 8.30% to $426.9 million in 2023, then grew by 1.00% to $431.2 million in 2024.